Inovalon (NASDAQ:INOV) issued an update on its first quarter earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $0.07 for the period, compared to the Thomson Reuters consensus estimate of $0.07. The company issued revenue guidance of $143-146 million, compared to the consensus revenue estimate of $146.84 million.

NASDAQ:INOV traded down $1.95 during midday trading on Thursday, reaching $13.47. 2,515,926 shares of the stock traded hands, compared to its average volume of 552,637. Inovalon has a 12-month low of $8.90 and a 12-month high of $15.57. The company has a quick ratio of 2.07, a current ratio of 2.07 and a debt-to-equity ratio of 1.36. The stock has a market capitalization of $2.28 billion, a price-to-earnings ratio of 58.57, a PEG ratio of 3.56 and a beta of 0.72.

Inovalon (NASDAQ:INOV) last posted its earnings results on Wednesday, February 20th. The technology company reported $0.05 EPS for the quarter, missing the Zacks’ consensus estimate of $0.07 by ($0.02). Inovalon had a negative net margin of 2.12% and a positive return on equity of 4.12%. The firm had revenue of $136.30 million for the quarter, compared to analysts’ expectations of $145.20 million. During the same period in the previous year, the company earned $0.06 EPS. The company’s revenue was up 18.9% on a year-over-year basis. As a group, analysts expect that Inovalon will post 0.22 EPS for the current year.

INOV has been the subject of a number of analyst reports. Morgan Stanley raised shares of Inovalon from an underweight rating to an equal weight rating and increased their target price for the company from $10.00 to $13.00 in a research report on Thursday, December 20th. SunTrust Banks assumed coverage on shares of Inovalon in a report on Friday, February 15th. They issued a buy rating and a $22.00 price target for the company. BidaskClub cut shares of Inovalon from a buy rating to a hold rating in a report on Thursday, November 1st. Wells Fargo & Co decreased their price target on shares of Inovalon from $14.00 to $11.00 and set a market perform rating for the company in a report on Thursday, November 8th. Finally, ValuEngine raised shares of Inovalon from a hold rating to a buy rating in a report on Friday, November 30th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Inovalon currently has a consensus rating of Buy and an average target price of $15.50.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at

Inovalon Company Profile

Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models in the healthcare industry. The company's platform enables the assessment and enhancement of clinical and quality outcomes and financial performance.

Further Reading: What are different types of coverage ratios?

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with's FREE daily email newsletter.